Literature DB >> 26385115

One Standardized Differentiation Procedure Robustly Generates Homogenous Hepatocyte Cultures Displaying Metabolic Diversity from a Large Panel of Human Pluripotent Stem Cells.

Annika Asplund1,2, Arvind Pradip1,3, Mariska van Giezen1, Anders Aspegren1, Helena Choukair1, Marie Rehnström1, Susanna Jacobsson1, Nidal Ghosheh2, Dorra El Hajjam1, Sandra Holmgren1,4, Susanna Larsson1, Jörg Benecke1, Mariela Butron1, Annelie Wigander1, Karin Noaksson1, Peter Sartipy2,5, Petter Björquist1,6, Josefina Edsbagge1, Barbara Küppers-Munther7,8.   

Abstract

Human hepatocytes display substantial functional inter-individual variation regarding drug metabolizing functions. In order to investigate if this diversity is mirrored in hepatocytes derived from different human pluripotent stem cell (hPSC) lines, we evaluated 25 hPSC lines originating from 24 different donors for hepatic differentiation and functionality. Homogenous hepatocyte cultures could be derived from all hPSC lines using one standardized differentiation procedure. To the best of our knowledge this is the first report of a standardized hepatic differentiation procedure that is generally applicable across a large panel of hPSC lines without any adaptations to individual lines. Importantly, with regard to functional aspects, such as Cytochrome P450 activities, we observed that hepatocytes derived from different hPSC lines displayed inter-individual variation characteristic for primary hepatocytes obtained from different donors, while these activities were highly reproducible between repeated experiments using the same line. Taken together, these data demonstrate the emerging possibility to compile panels of hPSC-derived hepatocytes of particular phenotypes/genotypes relevant for drug metabolism and toxicity studies. Moreover, these findings are of significance for applications within the regenerative medicine field, since our stringent differentiation procedure allows the derivation of homogenous hepatocyte cultures from multiple donors which is a prerequisite for the realization of future personalized stem cell based therapies.

Entities:  

Keywords:  Cellular therapy; Hepatocyte differentiation; Human embyronic stem cells; Human induced pluripotent stem cells; Liver; Toxicity

Mesh:

Substances:

Year:  2016        PMID: 26385115     DOI: 10.1007/s12015-015-9621-9

Source DB:  PubMed          Journal:  Stem Cell Rev Rep        ISSN: 2629-3277            Impact factor:   5.739


  50 in total

1.  Derivation, characterization, and differentiation of human embryonic stem cells.

Authors:  Nico Heins; Mikael C O Englund; Cecilia Sjöblom; Ulf Dahl; Anna Tonning; Christina Bergh; Anders Lindahl; Charles Hanson; Henrik Semb
Journal:  Stem Cells       Date:  2004       Impact factor: 6.277

2.  Large-scale propagation of four undifferentiated human embryonic stem cell lines in a feeder-free culture system.

Authors:  Eva Sjögren-Jansson; Mathilda Zetterström; Karina Moya; Jenny Lindqvist; Raimund Strehl; Peter S Eriksson
Journal:  Dev Dyn       Date:  2005-08       Impact factor: 3.780

3.  Nuclear receptor gene alteration in human induced pluripotent stem cells with hepatic differentiation propensity.

Authors:  Noriko Itaba; Peninah M Wairagu; Natsumi Aramaki; Toshihiro Yasui; Yoshiaki Matsumi; Yohei Kono; Ai N H Phan; Makoto Otsu; Takahiro Kunisada; Yukio Nakamura; Hideyuki Okano; Yangsik Jeong; Goshi Shiota
Journal:  Hepatol Res       Date:  2014-05-06       Impact factor: 4.288

4.  Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells.

Authors:  Karim Si-Tayeb; Fallon K Noto; Masato Nagaoka; Jixuan Li; Michele A Battle; Christine Duris; Paula E North; Stephen Dalton; Stephen A Duncan
Journal:  Hepatology       Date:  2010-01       Impact factor: 17.425

5.  Prediction of interindividual differences in hepatic functions and drug sensitivity by using human iPS-derived hepatocytes.

Authors:  Kazuo Takayama; Yuta Morisaki; Shuichi Kuno; Yasuhito Nagamoto; Kazuo Harada; Norihisa Furukawa; Manami Ohtaka; Ken Nishimura; Kazuo Imagawa; Fuminori Sakurai; Masashi Tachibana; Ryo Sumazaki; Emiko Noguchi; Mahito Nakanishi; Kazumasa Hirata; Kenji Kawabata; Hiroyuki Mizuguchi
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-10       Impact factor: 11.205

6.  Efficient generation of hepatocyte-like cells from human induced pluripotent stem cells.

Authors:  Zhihua Song; Jun Cai; Yanxia Liu; Dongxin Zhao; Jun Yong; Shuguang Duo; Xijun Song; Yushan Guo; Yang Zhao; Han Qin; Xiaolei Yin; Chen Wu; Jie Che; Shichun Lu; Mingxiao Ding; Hongkui Deng
Journal:  Cell Res       Date:  2009-09-08       Impact factor: 25.617

7.  Generation of liver disease-specific induced pluripotent stem cells along with efficient differentiation to functional hepatocyte-like cells.

Authors:  Arefeh Ghodsizadeh; Adeleh Taei; Mehdi Totonchi; Ali Seifinejad; Hamid Gourabi; Behshad Pournasr; Nasser Aghdami; Reza Malekzadeh; Navid Almadani; Ghasem Hosseini Salekdeh; Hossein Baharvand
Journal:  Stem Cell Rev Rep       Date:  2010-12       Impact factor: 5.739

8.  Human hepatocytes as an effective alternative experimental system for the evaluation of human drug properties: general concepts and assay procedures.

Authors:  Albert P Li
Journal:  ALTEX       Date:  2008       Impact factor: 6.043

9.  Gene expression in human hepatocytes in suspension after isolation is similar to the liver of origin, is not affected by hepatocyte cold storage and cryopreservation, but is strongly changed after hepatocyte plating.

Authors:  Lysiane Richert; Michael J Liguori; Catherine Abadie; Bruno Heyd; Georges Mantion; Nermin Halkic; Jeffrey F Waring
Journal:  Drug Metab Dispos       Date:  2006-02-10       Impact factor: 3.922

Review 10.  Human hepatocytes in primary culture: the choice to investigate drug metabolism in man.

Authors:  M J Gómez-Lechón; M T Donato; J V Castell; R Jover
Journal:  Curr Drug Metab       Date:  2004-10       Impact factor: 3.731

View more
  20 in total

Review 1.  Cell sources for in vitro human liver cell culture models.

Authors:  Katrin Zeilinger; Nora Freyer; Georg Damm; Daniel Seehofer; Fanny Knöspel
Journal:  Exp Biol Med (Maywood)       Date:  2016-07-05

Review 2.  Concise Review: Liver Regenerative Medicine: From Hepatocyte Transplantation to Bioartificial Livers and Bioengineered Grafts.

Authors:  Clara T Nicolas; Raymond D Hickey; Harvey S Chen; Shennen A Mao; Manuela Lopera Higuita; Yujia Wang; Scott L Nyberg
Journal:  Stem Cells       Date:  2016-10-02       Impact factor: 6.277

3.  Homogeneous Differentiation of Functional Hepatocytes from Human Induced Pluripotent Stem Cells.

Authors:  Rong Li; Yang Zhao; Jeffrey J Yourick; Robert L Sprando; Xiugong Gao
Journal:  Methods Mol Biol       Date:  2022

4.  Hepatic differentiation of human iPSCs in different 3D models: A comparative study.

Authors:  Florian Meier; Nora Freyer; Joanna Brzeszczynska; Fanny Knöspel; Lyle Armstrong; Majlinda Lako; Selina Greuel; Georg Damm; Eva Ludwig-Schwellinger; Ulrich Deschl; James A Ross; Mario Beilmann; Katrin Zeilinger
Journal:  Int J Mol Med       Date:  2017-10-16       Impact factor: 4.101

5.  Donor-Dependent and Other Nondefined Factors Have Greater Influence on the Hepatic Phenotype Than the Starting Cell Type in Induced Pluripotent Stem Cell Derived Hepatocyte-Like Cells.

Authors:  James A Heslop; Richard Kia; Christopher S Pridgeon; Rowena L Sison-Young; Triantafillos Liloglou; Mohamed Elmasry; Stephen W Fenwick; John S Mills; Neil R Kitteringham; Chris E Goldring; Bong K Park
Journal:  Stem Cells Transl Med       Date:  2017-05       Impact factor: 6.940

6.  Differentiation of human-induced pluripotent stem cell under flow conditions to mature hepatocytes for liver tissue engineering.

Authors:  Viktoriia Starokozhko; Mette Hemmingsen; Layla Larsen; Soumyaranjan Mohanty; Marjolijn Merema; Rodrigo C Pimentel; Anders Wolff; Jenny Emnéus; Anders Aspegren; Geny Groothuis; Martin Dufva
Journal:  J Tissue Eng Regen Med       Date:  2018-04-06       Impact factor: 3.963

7.  Highly Synchronized Expression of Lineage-Specific Genes during In Vitro Hepatic Differentiation of Human Pluripotent Stem Cell Lines.

Authors:  Nidal Ghosheh; Björn Olsson; Josefina Edsbagge; Barbara Küppers-Munther; Mariska Van Giezen; Annika Asplund; Tommy B Andersson; Petter Björquist; Helena Carén; Stina Simonsson; Peter Sartipy; Jane Synnergren
Journal:  Stem Cells Int       Date:  2016-02-01       Impact factor: 5.443

8.  Hepatic population derived from human pluripotent stem cells is effectively increased by selective removal of undifferentiated stem cells using YM155.

Authors:  Seok-Jin Kang; Young-Il Park; So-Ryeon Hwang; Hee Yi; Nga Tham; Hyun-Ok Ku; Jae-Young Song; Hwan-Goo Kang
Journal:  Stem Cell Res Ther       Date:  2017-04-17       Impact factor: 8.079

9.  HLA and Histo-Blood Group Antigen Expression in Human Pluripotent Stem Cells and their Derivatives.

Authors:  Karin Säljö; Angela Barone; Johan Mölne; Lennart Rydberg; Susann Teneberg; Michael E Breimer
Journal:  Sci Rep       Date:  2017-10-12       Impact factor: 4.379

10.  Hepatocyte-like cells derived from human induced pluripotent stem cells using small molecules: implications of a transcriptomic study.

Authors:  Xiugong Gao; Rong Li; Patrick Cahan; Yang Zhao; Jeffrey J Yourick; Robert L Sprando
Journal:  Stem Cell Res Ther       Date:  2020-09-11       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.